Wei Nong Ye
Director/Board Member presso China Biotech & Drug Development Ltd.
Provenienza dei contatti di primo grado di Wei Nong Ye
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Sun Yat-Sen University
60
| College/University | Other Consumer Services | 60 |
| Public Company | Pharmaceuticals: Major | 29 | |
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
 Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The private company is based in Dafeng, China.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Institut National des Sciences Appliquées de Toulouse
3
| College/University | Other Consumer Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Wei Nong Ye tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CHINA BLUECHEMICAL LTD. | Chemicals: Agricultural | Corporate Officer/Principal Chairman | |
| TIANJIN BINHAI TEDA LOGISTICS (GROUP) CORPORATION LIMITED | Air Freight/Couriers | Director/Board Member Director/Board Member Director/Board Member | |
| Michigan State University | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| CHINA OILFIELD SERVICES LIMITED | Contract Drilling | Corporate Officer/Principal Chairman | |
| BANK OF CHINA LIMITED | Major Banks | Director/Board Member Director/Board Member | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
LTT Bio-Pharma Co., Ltd.
 LTT Bio-Pharma Co., Ltd. BiotechnologyHealth Technology LTT Bio-Pharma Co. Ltd. engages in the research and development of drugs and new technologies. It also provides pharmaceuticals through drug delivery systems technology which delivers a required amount of drugs to the target site at the expected time; drug discovery; and dispensing pharmacy services. The company was founded by Yutaka Mizushima on April 1988 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Beijing Tide Pharmaceutical Co., Ltd.
 Beijing Tide Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Tide Pharmaceutical Co., Ltd. engages in research, development, manufacturing and sale of pharmaceutical products. The firm's products include kaifen flurbiprofen axetil injection, kaishi alprostadil injection, kaina beraprost sodium tablet and deyou pronase granules. The company was founded in May 1995 and is headquartered in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Chairman Chairman Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Corporate Officer/Principal | |
| University of Hong Kong | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Technology Sydney | College/University | Masters Business Admin Undergraduate Degree | |
| University of the Witwatersrand | College/University | Graduate Degree | |
| The Chinese University of Hong Kong | College/University | Doctorate Degree Undergraduate Degree | |
| Fudan University | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| Renmin University of China | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| The Hong Kong University of Science & Technology | College/University | Masters Business Admin Corporate Officer/Principal | |
Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd.
 Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Sino Biopharmaceutical Ltd., Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd. produces pharmaceutical products. The private company is based in Huaian, China. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Director/Board Member | |
Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd.
 Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sino Biopharmaceutical Ltd., Beijing Chia Tai Green Continent Pharmaceutical Co. Ltd. researches and produces new pharmaceutical products. The private company is based in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Hong Kong Institute of Certified Public Accountants
 Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| WUXI LIFE INTERNATIONAL HOLDINGS GROUP LIMITED | Packaged Software | Director/Board Member | |
Qingdao Chia Tai Haier Pharmaceutical Co. Ltd.
 Qingdao Chia Tai Haier Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Qingdao Chia Tai Haier Pharmaceutical Co. Ltd. manufactures and sells pharmaceuticals. It is a subsidiary of Chia Tai Wing Fuk Ltd. It is headquartered in Qingdao, China | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Qingdao Hengshengtang Drugstore Co., Ltd.
 Qingdao Hengshengtang Drugstore Co., Ltd. Drugstore ChainsRetail Trade Part of Sino Biopharmaceutical Ltd., Qingdao Hengshengtang Drugstore Co., Ltd. is a private company that retails pharmaceuticals. The company is based in Qingdao, China. | Drugstore Chains | Director/Board Member Director/Board Member | |
Qingdao Haier Medicine Co. Ltd.
 Qingdao Haier Medicine Co. Ltd. Medical DistributorsDistribution Services Part of Sino Biopharmaceutical Ltd., Qingdao Haier Medicine Co. Ltd. is a private company that distributes pharmaceuticals. The company is based in Qingdao, China. | Medical Distributors | Director/Board Member Director/Board Member | |
| Shenyang Pharmaceutical University | College/University | Undergraduate Degree Undergraduate Degree | |
| Harbin University of Commerce | College/University | Undergraduate Degree Undergraduate Degree | |
Pharmathen SA
 Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Nanjing Medical University | College/University | Doctorate Degree Doctorate Degree | |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member Chairman | |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Director/Board Member Director/Board Member | ||
| Friends of Hong Kong Association Ltd. | Corporate Officer/Principal Chief Executive Officer | ||
Yancheng Suhai Pharmaceutical Co., Ltd.
 Yancheng Suhai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Yancheng Suhai Pharmaceutical Co., Ltd. is a Chinese company that manufactures and distributes pharmaceutical products. The private company is based in Dafeng, China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Association of Chartered Certified Accountants (Hong Kong) | Corporate Officer/Principal Corporate Officer/Principal | ||
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| CT ENVIRONMENTAL GROUP LIMITED | Environmental Services | Director/Board Member Director/Board Member | |
| The Chinese Biopharmaceutical Association | President President | ||
| CT Green Continent Pharmaceutical Technology Co. Ltd. | Director/Board Member Director/Board Member | ||
Chia Tai Pharmaceutical Investment (Beijing) Co., Ltd.
 Chia Tai Pharmaceutical Investment (Beijing) Co., Ltd. Financial ConglomeratesFinance Part of Sino Biopharmaceutical Ltd., Chia Tai Pharmaceutical Investment (Beijing) Co., Ltd. operates as an investment holding Chinese company. The private company is based in Beijing, China. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | Director/Board Member Director/Board Member President Director/Board Member | ||
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Softhale NV
 Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Guangzhou China-blasting Digital Information Tech Co., Ltd.
 Guangzhou China-blasting Digital Information Tech Co., Ltd. Information Technology ServicesTechnology Services Guangzhou China-blasting Digital Information Tech Co., Ltd. provides technical and support services for the hazardous chemicals and explosive-related industries. It offers safety production supervision and management, flow supervision of dangerous goods, education and training of employees in hazardous and explosive industries, comprehensive supervision platform construction, application management information system construction, software development and operation, as well as sale of smart devices and smart terminal equipment. The company was founded on December 21, 2010 and is headquartered in Guangzhou, China. | Information Technology Services | Director/Board Member Director/Board Member | |
PHion Therapeutics Ltd.
 PHion Therapeutics Ltd. BiotechnologyHealth Technology PHion Therapeutics Ltd. operates as a therapeutic vaccine development company. Its vaccine program focuses on viral infections as it evokes a strong interferon gamma response. The firm's technology are RAVA and RAVA-V. The company was founded by Helen McCarthy in 2017 and is headquartered in Belfast, the United Kingdom. | Biotechnology | Director/Board Member | |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Investment Officer | |
Cp Pharmaceutical Qingdao Co. Ltd.
 Cp Pharmaceutical Qingdao Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Cp Pharmaceutical Qingdao Co. Ltd. is a private company that engages in the research and development, production, and sale of osteoporosis medicines and marine pharmaceuticals. Cp Pharmaceutical Qingdao Co. Ltd. is based in Qingdao, China. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| BEIJING SUPERMAP SOFTWARE CO., LTD. | Packaged Software | Corporate Officer/Principal Director/Board Member Founder | |
Sino Biopharmaceutical (Beijing) Ltd.
 Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Guanghua School of Management | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin |
Statistiche
Distribuzione geografica
| Cina | 28 |
| Hong Kong | 10 |
| Stati Uniti | 5 |
| Regno Unito | 3 |
| Svizzera | 2 |
Settori
| Consumer Services | 16 |
| Health Technology | 12 |
| Commercial Services | 7 |
| Finance | 4 |
| Technology Services | 4 |
Posizioni
| Director/Board Member | 325 |
| Corporate Officer/Principal | 142 |
| Independent Dir/Board Member | 117 |
| Undergraduate Degree | 83 |
| Chairman | 64 |
Contatti più connessi
| Insiders | |
|---|---|
| Ping Tse | 43 |
| Wei Cheng Diao | 28 |
| Zheng Fei Lu | 27 |
| Fei Yang | 24 |
| Jean Botti | 22 |
| Wei Li Hong | 19 |
| Kwok Tung Li | 17 |
| Feng Lian Zhu | 16 |
| Shi Quan Zeng | 16 |
| Bao Wen Zhang | 16 |
| Cheung Ling Cheng | 15 |
| Theresa Tse | 14 |
| Yun Ting Dong | 14 |
| Jian Hua Zou | 12 |
| Da Jan Yang | 12 |
- Borsa valori
- Insiders
- Wei Nong Ye
- Connessioni Società
